Organization Contact Information |
| Organization Name: |
ABC Genomics (india ) Pvt Ltd |
| Organization Street 1: |
Bioteh Park,Sector G,Jankipuram,Kursi Road |
| Organization Street 2: |
|
| Organization City: |
Lucknow |
| Organization Province: |
Uttar Pardesh |
| Organization Post Code: |
226021 |
| Organization Country: |
India |
| Organization Phone: |
0522-4068579 |
| Organization Email: |
director@abcgenomics.com |
| Organization Web Site: |
http://www.abcgenomics.com |
| |
Focal Point Contact Information |
| Focal Point Salutation: |
Mr |
| Focal Point First Name: |
Sabih |
| Focal Point Last Name: |
Farooqi |
| Focal Point Title: |
Managing Director |
| Focal Point Email: |
director@abcgenomics.com |
| |
Stop TB Partner Information |
| Organization Type: |
Corporate Sector (Health) |
| Organization Description: |
AquaBioChip Genomics is newly established Company working in the intersection of genomics, microfluidics and health. Since its inception in October 2007 it has established a cutting edge molecular biology lab in Uttar Pradesh (a state with large number of TB cases) established LAMP assay in our lab, acquired and tested primers for TB genotypes. |
| |
| How did you hear about the Stop TB Partnership: |
Attendance at a TB related event |
| |
| Why do you wish join the Stop TB Partnership: |
Information on developments within the TB world |
| |
| What TB activity\ies are you mainly involved in: |
Advocacy, communication and social mobilizationHealth Promotion
FundingResearch
Manufacture of TB productsDiagnostics
ResearchNew diagnostics
Technical AssistanceResearch |
| |
| Which Working Group(s) will you participate in: |
New Diagnostics |
| |
| No of staff who are directly involved with TB: |
1 - 5 |
| |
| Which country are you based in: |
India |
| |
| Which country/ies do you do operate in: |
India |
| |
| Which WHO region is the main focus of your work: |
South East Asian |
| |
| Are you a member of a Stop TB national partnership: |
No |
| |
|
Declaration of interests
Our interest is development of new diagnostics in the area of TB.
|
| |